Welcome to MBio!
MBio believes in efficient delivery of healthcare where rapid, affordable diagnostic tests are deployed where and when they are needed. Our proprietary LightDeck® platform delivers lab-quality results almost anywhere in minutes. We are developing a portfolio of multiplex panels for COVID-19, host-response tests for acute infections and sepsis, and cardiac markers. The LightDeck platform has been commercialized successfully for veterinary diagnostics and environmental testing.
The LightDeck platform consists of a robust, portable fluorescence analyzer and disposable, multiplex test cartridges. The test procedure is simple enough that an untrained user can generate lab-quality results almost anywhere. Panels can be configured to run multiple related tests simultaneously to help diagnosis or rule-out a specific condition.
Lab-Quality Testing Almost Anywhere
We are developing a portfolio of IVD point-of-care tests and multiplex panels.
The LightDeck COVID-19 Total Antibody Test is to determine past SARS-CoV-2 infection and potential immunity.
Host-response biomarkers signal “out of control” immune response in acute infection.
We are developing a NextGen test for heart attack: a high-sensitivity troponin test for the emergency department.